Literature DB >> 21073735

Construction of metabolically biotinylated adenovirus with deleted fiber knob as targeting vector.

Yanzheng Liu1, Philippe Valadon, Jan E Schnitzer.   

Abstract

Gene delivery vectors based on adenovirus, particularly human adenovirus serotype 5 (hAd5) have great potential for the treatment of variety of diseases. However, the tropism of hAd5 needs to be modified to achieve tissue- or cell- specific therapies for the successful application of this vector system to clinic. Here, we modified hAd5 tropism by replacing the fiber knob which contains the coxsackievirus B and adenovirus receptor (CAR)-binding sites with a biotin acceptor peptide, a truncated form of Propionibacterium shermanii 1.3 S transcarboxylase domain (PSTCD), to enable metabolically biotinylation of the virus. We demonstrate here that the new adenovirus no longer shows CAR-dependent cell uptake and transduction. When metabolically biotinylated and avidin-coated, it forms a nano-complex that can be retargeted to distinct cells using biotinylated antibodies. This vector may prove useful in the path towards achieving targeted gene delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073735      PMCID: PMC2993673          DOI: 10.1186/1743-422X-7-316

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  17 in total

1.  Screening phage display libraries for organ-specific vascular immunotargeting in vivo.

Authors:  Philippe Valadon; Jeff D Garnett; Jacqueline E Testa; Marc Bauerle; Phil Oh; Jan E Schnitzer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-29       Impact factor: 11.205

Review 2.  The influence of adenovirus fiber structure and function on vector development for gene therapy.

Authors:  Stuart A Nicklin; Eugene Wu; Glen R Nemerow; Andrew H Baker
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

3.  Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Virology       Date:  2006-02-28       Impact factor: 3.616

4.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

5.  Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo.

Authors:  Philippe Valadon; Bryan Darsow; Tim N Buss; Malgorzata Czarny; Noelle M Griffin; Han N Nguyen; Phil Oh; Per Borgstrom; Adrian Chrastina; Jan E Schnitzer
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

6.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

8.  Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.

Authors:  Dmitry M Shayakhmetov; Anuj Gaggar; Shaoheng Ni; Zong-Yi Li; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.

Authors:  Yanzheng Liu; Tao Ye; Dejun Sun; Jonathan Maynard; Albert Deisseroth
Journal:  Hum Gene Ther       Date:  2004-07       Impact factor: 5.695

10.  Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes.

Authors:  Alan L Parker; Simon N Waddington; Campbell G Nicol; Dmitry M Shayakhmetov; Suzanne M Buckley; Laura Denby; Geoffrey Kemball-Cook; Shaoheng Ni; Andre Lieber; John H McVey; Stuart A Nicklin; Andrew H Baker
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.